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ABBREVIATIONS 
CPET, cardiopulmonary exercise test 
CT, computed tomography 
HCC, hepatocellular carcinoma 
MELD-Na, model of end stage liver disease, incorporating serum sodium 
SATI, subcutaneous adipose tissue index 
SMI, skeletal muscle index 
VATI, visceral adipose tissue index 
V E, minute ventilation 
V E V C 2, ventilatory equivalents for carbon dioxide 
V E V  2, ventilatory equivalents for oxygen 
V O2, volume of oxygen 
V CO2, volume of carbon dioxide 
VT, ventilatory threshold 
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ABSTRACT 
 
Background: Patients with advanced liver disease are at increased risk of infection 
and other complications. A significant proportion of patients also have poor fitness 
and low muscle mass. The primary aim of this study was to investigate if 
cardiorespiratory fitness and body composition are risk factors for sepsis and other 
complications of advanced liver disease.  
 
Methods: Patients being listed for liver transplantation underwent cardiopulmonary 
exercise testing to determine ventilatory threshold (VT). Computed tomography was 
used to measure skeletal muscle and subcutaneous and visceral adipose tissue indexes. 
All unplanned hospital admissions, deaths or delistings prior to transplantation were 
recorded. 
 
Results: Eighty-two patients [aged 55.1 (50.6–59.4) years, median (interquartile 
range); male 87%] achieved a median VT of 11.7 (9.7–13.4) mL∙kg-1∙min-1. Their 
median MELD-Na score was 18 (14–22); and 37 had hepatocellular carcinoma. There 
were 50 admissions in 31 patients; with 16 admissions for sepsis in 13 patients. 
Patients with sepsis had a significantly lower VT [sepsis 9.5 (7.8–11.9), no sepsis 11.8 
(10.5–13.8) mL∙kg-1∙min-1; P=0.003]. No body composition variables correlated with 
sepsis, nor were there any significant associations between VT and unplanned 
admissions for other indications. Multivariate logistic regression demonstrated that 
VT was independently associated with a diagnosis of sepsis (P=0.03). Poisson 
regression revealed that VT was a significant predictor for the number of septic 
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episodes (P=0.02); independent of age, MELD-Na score, hepatocellular carcinoma 
diagnosis, presence of ascites, and beta-blocker use. 
 
Conclusion: Poor cardiorespiratory fitness is an independent risk factor for the 
development of sepsis in advanced liver disease.  
AC
CE
PT
ED
Copyright © Wolters Kluwer Health. Unauthorized reproduction of this article is prohibited.
 
6 
INTRODUCTION 
 
Cardiopulmonary exercise testing (CPET) is recognised as the gold-standard 
assessment of cardiorespiratory fitness. Several large-scale cohort studies in healthy 
populations have shown a correlation between low cardiorespiratory fitness 
(measured as maximal oxygen consumption (V O2max)) and adverse cardiometabolic 
events. Indeed, cardiorespiratory fitness appears to be a stronger predictor than 
obesity for all cause morbidity and mortality 
1-3
. 
 
Patients with advanced liver disease often have poor cardiorespiratory fitness 
compared to sedentary but otherwise healthy, control subjects 
4,5
. During CPET in 
patients with advanced liver disease, V O2max may not be achieved due to peripheral 
fatigue resulting in an inability to attain a plateau in oxygen consumption despite an 
increase in exercise intensity (the criteria for maximal V O2max). The ventilatory 
threshold (VT) is a submaximal marker of cardiorespiratory fitness assessed during a 
CPET. It is defined as the point at which there is a nonlinear increase in ventilation 
with an increase in workload and is associated with the onset of increased anaerobic 
metabolism 
6
. Several investigations have highlighted the importance of VT as a peri-
transplant risk stratification tool 
7-9
, likely because the VT reflects available 
cardiorespiratory reserve to deal with the augmented tissue oxygen demand from 
systemic inflammation after surgery 
10
. 
 
Sepsis is a major cause of morbidity and mortality in patients with advanced liver 
disease. Approximately 1-third of patients with cirrhosis admitted to hospital will 
have a bacterial infection 
11-13
. Importantly, patients with cirrhosis hospitalized with 
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sepsis have a fourfold increased risk of dying within 1 year of developing these 
infections 
14
. Sarcopenic obesity 
15
 and excessive visceral adipose tissue deposits 
16
 
appear to predispose this cohort to sepsis. Tissue demand for oxygen is increased in 
sepsis, in part due to altered oxygen extraction 
17
, and hence cardiorespiratory fitness 
may impact on outcomes in sepsis. However, the relationship between a formal 
assessment of cardiorespiratory fitness and sepsis is yet to be established.  
 
The aim of this study was to determine if VT is independently associated with sepsis 
and other complications of advanced liver disease in patients awaiting liver 
transplantation. Additionally, we sought to determine the relationships between VT, 
central adiposity, muscle mass and hospitalizations in this population. 
 
MATERIALS AND METHODS 
This was a retrospective cohort analysis of consecutive patients from October 2012 to 
June 2015 at a single study center (The Princess Alexandra Hospital, Woolloongabba, 
Queensland, Australia). All patients included in the analysis were listed for liver 
transplantation and had performed CPET and undergone a computed tomography 
(CT) scan prior to listing. Metro South Hospital and Health Services District and The 
University of Queensland’s Human Research Ethics Committees granted ethical 
approval for the study (Approval numbers: HREC/14/QPAH/714; HMS13/1210). A 
waiver of consent to assess patient medical records was obtained under the 
Queensland Government Public Health Act. Patients were excluded from the study if 
they were less than 18 years old; diagnosed with underlying cholestatic liver disease; 
had previously received a liver transplant; listed for dual organ transplantation; and/or 
did not achieve VT during CPET. 
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Clinical data collection 
Patient medical records were retrospectively examined for demographic (age, sex) 
and clinical factors at the time of the CPET [aetiology of liver disease (viral, alcohol, 
other); model of end-stage liver disease (MELD)-Na score; diagnosis of 
hepatocellular carcinoma (HCC); presence of ascites and gastroesophageal varices; 
and the use beta-blockers]. Laboratory parameters recorded at baseline included 
serum sodium, creatinine, bilirubin, albumin, alanine transaminase, aspartate 
aminotransferase, alkaline phosphatase, gamma-glutamyl transferase, and platelet 
count (Table 1).  
 
The diagnosis of sepsis was assessed from the time of transplant listing until death, 
delisting, or liver transplantation. One author (AW) reviewed all hospital admissions 
for the cohort and confirmed reason for admission, including the diagnoses of sepsis 
requiring hospital admission, which was defined per international consensus 
guidelines 
18
. Briefly, sepsis was diagnosed on the basis of a) documented infection 
induced by a microorganism and b) physical and/or laboratory signs of systemic 
inflammation in response to infection 
18
. Each episode of sepsis was considered 
clinically significant as the patients required hospital admission and the administration 
of antibiotics.  
 
Cardiopulmonary exercise testing (CPET) 
In the study center, a CPET is performed routinely to assist with risk stratification 
prior to liver transplant surgery. All tests were performed on an upright cycle 
ergometer (Lode Corival, Groningen, Netherlands) with continuous gas exchange 
analysis and 12-lead electrocardiography (Ultima CardiO2, MGC Diagnostics, St. 
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Paul, MN, USA). Patients adhered to pretest procedures as per the position statement 
by the American Thoracic Society and American College of Chest Physicians for 
Cardiopulmonary Exercise Testing, and were advised to maintain their usual 
medication dosages prior to CPET, including beta-blocker prophylaxis 
19
. Standard 
calibration of gas analyzers (2 point calibration against 2 gravimetric gas standards: 
21% oxygen, balance nitrogen and 5% carbon dioxide/ 12% oxygen, balance 
nitrogen) and volume (Hans Rudolph
TM
 3L calibration syringe) were performed as per 
manufacturer’s recommendations.  
 
Patients performed the CPET with breath-by-breath gas analysis. Testing was ceased 
if patients satisfied any indications for exercise termination  (eg, ischemic 
electrocardiography changes; oxygen desaturation to ≤ 80% accompanied by signs 
and symptoms of severe hypoxemia) 
19
. VT was determined using the modified V-
slope method included in the BreezeSuite software (MGC Diagnostics, St. Paul, MN, 
USA), as the V O2 value corresponding with the nonlinear increase in the V O2-V CO2 
slope. This value was confirmed using the ventilatory equivalents method, where VT 
was selected at the time-point consistent with the first continual increase in the 
ventilatory equivalents of VO2 (V E/V O2), with no consistent increase in the 
ventilatory equivalents for V CO2 (V E/V CO2) 
20,21
. A physician supervised the CPET 
(AH) and performed the analysis with the lead investigator (MW).  
 
Computed Tomography (CT) analysis of muscle mass and central obesity 
CT scanning was performed as part of standard liver transplant assessment prior to 
listing. Body composition data was obtained from a transverse CT image at the third 
lumbar vertebrae using ImageJ software (National Institute of Health, Bethesda, MD, 
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USA). All images were analysed by a single observer (AW) who was blinded to the 
CPET results, and who cross-validated 10 images with a radiologist with minimal 
interobserver variability (intraclass coefficient = 0.99). Tissue segmentation was 
performed using Hounsfield unit thresholds of -29 to +150 for muscle and -190 to -30 
for adipose tissue. The cross-sectional areas of subcutaneous adipose tissue, visceral 
adipose tissue and muscle were normalised for stature (cm
2
/height
2
), and described as 
subcutaneous adipose tissue index (SATI), visceral adipose tissue index (VATI) and 
skeletal muscle index (SMI) 
22
. 
 
Statistical analysis 
All continuous data were assessed for normality using a Shapiro-Wilk test and 
expressed as mean ± standard deviation, unless otherwise reported. Mann-Whitney U 
(for continuous, nonnormally distributed data), or independent t tests (for continuous, 
normally distributed data) were used to compare variables associated with hospital 
admission. Between-group analyses also compared differences in liver disease 
severity scores, cardiorespiratory fitness and body composition indices between 
patients where the primary indication for transplant listing was hepatocellular 
carcinoma. A Kruskal-Wallis test explored the difference in VT, SATI, VATI and 
SMI between those who had 0, 1 or 2 sepsis-related hospital admissions. Post hoc 
pairwise comparisons were performed using Dunn’s method with Bonferroni 
corrections to account for multiple comparisons. Multivariate logistic regression 
examined the associations between the development of sepsis and clinically relevant 
predictors, including patient age (in years), MELD-Na score at the time of CPET, 
diagnosis of HCC, presence of ascites, use of beta-blocker medication, and the VT. 
These variables were also used as exposures in a multivariate Poisson regression to 
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calculate the incidence rate ratios for developing 1 or more episodes of sepsis 
requiring hospital admission from the time of listing until death, removal from the 
waiting list, liver transplantation or the final date of data collection (June 2015). 
Patient waitlist duration was used as the offset variable in the model. To determine 
whether associations between VT and hospital admission were specific for sepsis, the 
analysis was also undertaken for all hospital admissions and unplanned admissions for 
other complications of advanced liver disease, specifically hepatic encephalopathy, 
variceal bleeding and fluid overload. Finally, a receiver-operator characteristic (ROC) 
curve was performed using VT to determine the accuracy of predicting sepsis-related 
hospital admission. The optimal-cut off value with the highest sensitivity and 
specificity for VT was determined as the value closest to the upper left corner on the 
plot. All analyses were performed using a statistical software package (SPSS, Version 
24, IBM, New York, USA) and statistical significance was assumed if P < 0.05. 
 
RESULTS 
Patient characteristics 
There were 126 consecutive patients listed for liver transplantation during the study 
period. Patients with cholestatic liver disease (n = 18); those listed for acute liver 
failure (n = 9); or who did not perform a CPET (n = 12); and those with incomplete 
CPET or CT data (n = 5) were excluded. Eighty-two patients who performed a CPET 
as part of their evaluation prior to liver transplantation were included in the analysis. 
Seven patients were subsequently delisted, 5 patients because they deteriorated and 
were deemed too sick for transplant, and 2 due to progression of their HCC. No 
patient was delisted due to a poor VT. The majority of patients were male (87%) and 
approximately half the cohort had radiologically-diagnosed hepatocellular carcinoma 
AC
CE
PT
ED
Copyright © Wolters Kluwer Health. Unauthorized reproduction of this article is prohibited.
 
12 
(45.1%) as the primary indication for liver transplantation. The median age 
(interquartile range) was 55.1 (50.6 – 59.4) years and MELD-Na score was 18 (13.8 – 
22.0). Viral hepatitis was the most frequent cause of chronic liver disease (48.8%), 
followed by alcohol (36.6%), and then genetic or lifestyle-related conditions (eg, 
nonalcoholic fatty liver disease) (14.6%). Gastroesophageal varices were present in 
78.0% of the patients at the time of CPET. There were 3 patients with 
hepatopulmonary syndrome and 1 with mild portopulmonary hypertension in the 
cohort. The majority of the cohort (80.5%) underwent liver transplantation during the 
data collection period. Seven patients were delisted (8.5%) and a further 9 (11%) 
remained on the waitlist at the end of the study period. There were no deaths. 
 
There were fifty unplanned hospital admissions in thirty-one patients prior to liver 
transplantation, with multiple unplanned admissions in 14 patients (10 patients had 2 
admissions, 3 had 3 admissions, and 1 patient had 4 admissions). There were twenty-
seven admissions for complications of advanced liver disease: twelve patients had 
fifteen admissions with fluid overload (ascites/hydrothorax/oedema) or complications 
of managing this (hyponatraemia, postural hypotension); 10 patients had 1 admission 
each for hepatic encephalopathy, and 2 patients were admitted once after variceal 
haemorrhage. Sixteen hospital admissions in thirteen patients were for sepsis, 
including 3 patients with 2 episodes each. The remaining 7 unplanned admissions 
were for abdominal pain and a clinical concern about possible spontaneous bacterial 
peritonitis in 2 patients; and 1 patient each with symptomatic portal vein thrombosis, 
nephrolithiasis, seizures, falls, and diarrhea.  
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The nature of the septic episodes included spontaneous bacterial peritonitis (n = 6), 
positive blood cultures (n = 3), urinary tract infection (n = 2) and Campylobacter 
enteritis (n = 2). The remaining episodes were single events that included cellulitis (n 
= 1), aspergillus pneumonitis (n = 1) and a lower respiratory tract infection (n = 1). 
Three patients had 2 separate admissions with sepsis. These infective episodes were 
due to 2 episodes of spontaneous bacterial peritonitis in 1 patient, 2 urinary tract 
infections in the second patient, with the final patient having an episode of 
spontaneous bacterial peritonitis and another of aspergillus pneumonitis. Twelve 
patients received secondary prophylaxis with antibiotics to prevent recurrent 
infection. Five of these 12 patients developed an episode of sepsis requiring hospital 
admission. 
 
Patients diagnosed with sepsis had significantly lower serum sodium (P = 0.02), 
significantly higher bilirubin (P = 0.009) and MELD-Na score (P = 0.03), and were 
more likely to have documented ascites (P = 0.049) (Table 1). No significant 
differences were found between the groups for the remaining demographic and 
clinical characteristics. 
 
There were no adverse events during CPET that required hospitalisation or medical 
assistance. The median VT for the cohort was 11.7 (9.7 – 13.4) mL∙kg-1∙min-1. The 
average VT for patients with diagnosed hepatopulmonary syndrome or 
portopulmonary hypertension was 12.2 mL∙kg-1∙min-1. Patients who developed a 
septic episode had a significantly lower VT [9.5 (7.8 – 11.9) mL∙kg-1∙min-1] than those 
who did not develop sepsis [11.8 (10.5 – 13.8) mL∙kg-1∙min-1] (P < 0.01). There was 
also a significant difference in the VT based on the number of septic episodes (P = 
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0.01). Patients who were receiving beta-blockers at the time of CPET had a 
significantly lower VT [10.5 (9.0 – 13.3) mL∙kg-1∙min-1], compared to those who were 
not taking the medication [12.3 (10.9 – 13.7) mL∙kg-1∙min-1] (P = 0.017).  
 
There were 23 patients with CP–A cirrhosis. Four patients with CP-A cirrhosis had a 
VT ≤ 10 mL∙kg-1∙min-1, with one of these patients admitted for sepsis. HCC patients 
also had a significantly greater VT (13.2 ± 3.6 mL∙kg-1∙min-1) compared to patients 
without a HCC (11.1 ± 2.5 mL∙kg-1∙min-1) (P < 0.01) (Table S1, 
http://links.lww.com/TP/B602). However, 3 patients with HCC had 4 admissions for 
sepsis. One patient had 2 admissions for UTI’s; another was admitted for a LRTI; 
while the final patient had a positive blood culture with unknown cause. All causes of 
sepsis were independent of loco regional treatment (TACE or RFA) for HCC.  
 
There were no significant correlations between CT-derived measures of body 
composition and admissions for sepsis, variceal haemorrhage, fluid overload, or for 
any other unplanned admission. Patients admitted for hepatic encephalopathy had 
significantly greater SATI (P < 0.01) and VATI (P = 0.02), but not SMI (P = 0.12). 
No correlations between body composition variables and the number of admissions 
for sepsis were found.  
 
Multivariate logistic regression revealed that the VT was independently associated 
with the development of sepsis (Odds ratio = 0.675, 95% CI = 0.471 – 0.965, P = 
0.03). The VT was not significantly associated with admissions for variceal 
haemorrhage, fluid overload, hepatic encephalopathy, or any other indication.  
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Multivariate analysis incorporating individual body composition variables into the 
model revealed that SATI (P < 0.01), VATI (P = 0.04) and SMI (P = 0.024) were 
associated with admissions for hepatic encephalopathy. When all body composition 
parameters were included in the same model, only SATI retained significance (Odds 
ratio = 1.033, 95% CI = 1.003 – 1.063, P = 0.03). There were no associations found 
between body composition measures and admissions for sepsis, variceal haemorrhage, 
fluid overload or other indications. 
 
Results of the multivariate Poisson regression analysis adjusted for liver transplant 
waitlist duration are shown in Table 2. Pretransplant VT remained the only 
significant predictor of number of septic episodes (P = 0.02). This was independent of 
age, MELD-Na score, HCC diagnosis, presence of ascites, and the use of beta-blocker 
prophylaxis. 
 
Prediction of a sepsis-related hospital admission using VT 
ROC curve analysis of VT to predict sepsis demonstrated 69.2% sensitivity and 
81.2% specificity, with the area under the curve calculated as 0.76 [95% CI 0.599 – 
0.913 (P < 0.01)] (Figure 1). The optimal cut-off value of VT to identify patients who 
went on to develop a septic episode was ≤ 10.0 mL.kg-1.min-1, with 9 (69.2%) of 
thirteen patients admitted with sepsis having a VT ≤ 10.0 mL.kg-1.min-1 (Figure 2). 
 
DISCUSSION 
This is the first study to examine the relationship between cardiorespiratory fitness 
and the development of complications of liver disease requiring hospital admission in 
patients awaiting liver transplantation. The main finding was that the VT was 
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associated with the development of clinically significant infections, independent of 
age, MELD-Na score, HCC diagnosis and the presence of ascites in patients with 
advanced liver disease. The patients who experienced a septic episode had 
significantly lower VTs compared to those who did not. There was no association 
between measures of muscle mass or central obesity and the subsequent development 
of sepsis requiring hospital admission. These data emphasise the utility of assessing 
cardiorespiratory fitness using VT to identify patients with advanced liver disease 
who are at an increased risk of developing sepsis. 
 
CPET provides valuable insight into a patient’s cardiopulmonary reserve to cope with 
physiological stresses such as infection. Poorer cardiorespiratory fitness prior to liver 
transplantation is associated with higher peri-transplant morbidity and mortality 
7,9
; 
while physical inactivity has been shown to correlate with the risk of sepsis in the 
general population 
23
. However the relationship between cardiorespiratory fitness and 
complications prior to liver transplantation is relatively unexplored. Ow and 
colleagues recently examined the prognostic value of CPET in predicting 30- and 90-
day waitlist mortality 
24
. They found that patients with a U   odel for End-Stage 
Liver Disease  U ELD  score      and peak V  2 ≤ 1 .6 mL.kg
-1
.min
-1 had a  8% 
higher risk of mortality compared to those with peak V  2 > 17.6 mL.kg
-1
.min
-1
, with 
sepsis accounting for 30% of the waiting list deaths. Although there were no deaths in 
our cohort, the association between a low VT and a greater incidence of sepsis 
reported here may in part explain the increased mortality reported in this previous 
investigation. 
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The specific mechanisms linking impaired cardiorespiratory fitness and increased risk 
for sepsis are currently unknown. Patients with advanced liver disease may exhibit 
ventilation-perfusion mismatching and tissue hypoxemia as a result of vasodilation 
and arteriovenous shunting 
25-27
. An impaired ability to augment tissue oxygen 
delivery in cirrhosis might increase the risk of bacteria translocation from the gut, 
causing clinically significant infections 
28
. As well as increasing the risk of infection, 
these changes may reduce the effectiveness of innate immune responses to clear 
infections. 
 
Sarcopenic obesity has previously been shown to be associated with a greater 
incidence of sepsis-related mortality in patients with cirrhosis 
15
. This relationship has 
been attributed to protein malnutrition and liver disease-related irregularities in energy 
metabolism 
29
. Low muscle mass may contribute to a reduced reserve to tolerate 
physiological stressors 
30,31
, while visceral adipose tissue is associated with increased 
inflammatory and oxidative stress biomarkers 
16
. However, we found no significant 
differences in SMI and VATI between patients who did or did not develop an episode 
of sepsis.  
 
Although the data presented here highlights that cardiorespiratory fitness appears to 
have utility in identifying those at increased risk of developing sepsis, there is overlap 
with the VT of some of the patients who did not develop sepsis. Because of this 
overlap, the data presented here do not support the use of antibiotic prophylaxis in 
patients with a low VT. Nonetheless, it would be important to further understand the 
physiological mechanisms linking cardiorespiratory fitness and infection risk. 
Furthermore, it would also be logical to investigate whether interventions known to 
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increase cardiorespiratory fitness such as exercise training may reduce the incidence 
of sepsis, and improve pre, peri- and postoperative outcomes in patients with 
advanced liver disease.  
 
There is currently a paucity of randomised-controlled trials evaluating an exercise 
training intervention in patients with decompensated liver disease. Moreover, mixed 
results have been reported in the small number of clinical trials that have examined 
the efficacy of moderate continuous exercise training to improve cardiorespiratory 
fitness in compensated cirrhosis 
32-34
. These inconsistent findings are likely due to 
small sample sizes, and require further validation in a larger cohort with 
decompensated liver disease. 
 
A limitation of this investigation was the retrospective study design and also the 
relatively small sample size to evaluate the association between CPET variables and 
clinical outcomes. Additionally, all body composition variables were analysed from a 
single CT slice, normalised for patient height. This approach does not include the 
potential influence of appendicular fat or muscle on the risk of sepsis. Nonetheless, 
single slice CT or MRI evaluations of muscle and fat are widely used and accepted 
measures of body composition. 
 
In summary, we report evidence that cardiorespiratory fitness (as measured by VT) in 
patients with advanced liver disease appears to protect patients from severe sepsis; 
and that CPET can identify patients at increased risk of sepsis-related hospitalisation. 
This may have implications for using CPET results in prioritizing organ allocation to 
patients on a liver transplant waiting list. In addition to validating this finding in other 
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cohorts at risk of sepsis, exercise training should be investigated to determine if 
improving VT reduces the risk of sepsis in patients with advanced liver disease. 
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Figure 1. Sensitivity and specificity analysis of ventilatory threshold for predicting 
the diagnosis of sepsis.  ptimal ventilatory threshold ≤10.0 mL.kg-1.min-1, area under 
the receiver operator characteristic curve = 0.74, 95% CI = CI 0.568-0.921, P < 0.01) 
 
Figure 2. Plot of the ventilatory threshold versus the diagnosis of a septic episode 
prior to liver transplantation. Circles represent a ventilatory threshold ≤ 10 mL.kg-
1
.min
-1
. Squares represent a ventilatory threshold > 10 mL.kg
-1
.min
-1
. 
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Figure 2 
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Table 1. Demographic, laboratory, cardiopulmonary exercise testing and body 
composition data of patients with advanced liver disease who either had, or did not 
have a septic episode prior to liver transplantation 
  Overall (n=82) Sepsis (n=13) No Sepsis (n=69) 
P 
value 
Demographics     
 Age (years) 55.1 (50.6-59.4) 53.4 (50.1-57.9) 55.5 (50.5-59.5) 0.37 
 Sex: male [n (%)] 71 (86.6%) 12 (92.3%) 59 (85.5%) 0.51 
 Etiology [n (%)]     
  Viral 40 (48.8%) 6 (46.2%) 34 (49.3%) 0.84 
  Alcohol 30 (36.6%) 5 (38.5%) 25 (36.2%) 0.88 
  Other 12 (14.6%) 2 (15.4%) 10 (14.5%) 0.93 
 MELD-Na score 18.0 (13.8.0-22.0) 21.0 (18.0-26.5) 17.0 (13.0-22.0) 0.03 
 Child-Pugh score 9 (6-10) 10 (8.5-12) 8 (6-10)_ 0.02 
 
Child-Pugh class 
(A/B/C) 23/27/32 1/4/8 22/23/24 0.12 
 HCC: yes [n (%)] 37 (45.1%) 3 (23.1%) 34 (45.1%) 0.08 
 Waitlist time (days) 84.5 (35.5-160.3) 110.0 (47.0-195.0) 82.0 (33.5-154.0) 0.31 
 Ascites: yes [n (%)] 49 (59.8%) 11 (84.6%) 38 (55.1%) 0.049 
 
Gastroesophageal 
varices: yes [n (%)] 64 (78.0%) 9 (69.2%) 55 (79.7%) 0.40 
 
Beta-blockers: yes  
[n (%)] 35 (42.7%) 8 (61.5%) 27 (39.1%) 0.13 
Laboratory      
 Sodium (mmol/L) 136.0 (132.8-138.0) 132.0 (129.0-136.5) 136.0 (133.5-138.0) 0.02 
 Creatinine (μmol/L) 73.0 (58.5-93.25) 78.0 (62.0-108.0) 73.0 (57.5-91.5) 0.18 
 Bilirubin (μmol/L) 40.0 (29.8-70.0) 64.0 (44.0-97.0) 37.0 (24.5-65.0) 0.009 
 
Platelet count 
(x109/L) 76.0 (57.3-123.3) 89.0 (55.0-114.0) 74.0 (57.5-125.5) 0.94 
 Albumin (g/L) 30.0 (26.0-37.0) 28.0 (23.5-34.5) 30.0 (26.0-37.0) 0.39 
 
Alanine 
transaminase (U/L) 51.0 (29.8-96.3) 36.0 (25.5-86.0) 51.0 (32.0-96.5) 0.40 
 
Aspartate 
aminotransferase 
(U/L) 76.0 (53.5-144.5) 73.0 (56.5-145.5) 77.5 (53.0-145.3) 0.91 
 
Gamma-glutamyl 
transferase (U/L) 47.0 (32.8-77.3) 43.0 (23.5-55.0) 50.0 (34.5-80.0) 0.26 
 
Alkaline 
phosphatase (U/L) 111.5 (88.8-143.0) 123.0 (95.0-183.5) 110.0 (88.5-139.0) 0.24 
CPET variables 
 VT (mL∙kg-1∙min-1) 11.7 (9.7-13.4) 9.5 (7.8-11.9) 11.8 (10.5-13.8) 0.003 
Body composition 
measures     
 SATI (cm2/height2) 57.1 (39.5-79.2) 59.9 (40.2-95.0) 56.5 (39.3-78.7) 0.52 
 VATI (cm2/height2) 42.8 (27.1-60.2) 35.6 (24.1-48.2) 44.0 (27.3-61.0) 0.27 
 SMI (cm2/height2) 52.0 ± 8.6 50.2 ± 7.5 52.3 ± 8.8 0.41 
Values presented as mean ± SD, or median (interquartile range) where data were not normally 
distributed, unless otherwise stated. MELD-Na = model of end-stage liver disease, 
incorporating serum sodium; HCC = hepatocellular carcinoma; CPET = cardiopulmonary 
exercise testing; VT = ventilatory threshold; SATI = subcutaneous adipose tissue index; 
VATI = visceral adipose tissue index; SMI = skeletal muscle index 
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Table 2. Incidence rate ratios (IRR) for overall sepsis diagnoses prior to liver 
transplantation 
 
Variable IRR 95% CI P value 
Age (years) 0.992 0.938-1.049 0.79 
MELD-Na score 1.052 0.907-1.219 0.51 
HCC (yes) 1.427 0.400-5.082 0.58 
Ascites (yes) 0.767 0.179-3.293 0.85 
Beta-blockers (yes) 0.940 0.302-2.929 0.92 
VT (mL.kg-1.min-1) 0.769 0.622-0.951 0.02 
 
MELD-Na = model of end-stage liver disease, incorporating serum sodium; HCC = 
hepatocellular carcinoma; VATI = visceral adipose tissue index; SMI = skeletal 
muscle index; VT = ventilatory threshold 
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